Up to 84 percent of individuals with irritable bowel syndrome (IBS) perceive diet as a trigger to their GI distress. The most researched evidenced based nutritional therapy for IBS is the low FODMAP diet. Although 50-70 percent of IBS patients will effectively manage their digestive symptoms with the low FODMAP diet, it is not an intervention for all IBS patients. IBS symptoms can present in other conditions such as in celiac disease, inflammatory bowel disease and even in endurance athletes.

Join Kate Scarlata, MPH, RDN, LDN, on Wednesday, May 27, 2020 from 2-3 p.m. EDT for a webinar that will focus on understanding how reducing FODMAP carbohydrates may be helpful in these patient populations. Dietitians should be able to select the best candidate for a three-phase low FODMAP diet as well as know when to offer a more flexible application of the diet, called "FODMAP gentle." Additionally, dietitians should be able to assess which patients might be best suited for non-diet interventions as first line therapy for symptom management. This session will cover the three-phase application of the low FODMAP diet, explain what a FODMAP gentle approach entails, and discuss other modalities to consider in your IBS patients when an exclusion diet is contraindicated.